- Home
- COKE vs ASND Comparison
COKE vs ASND Comparison
Compare COKE & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COKE
- ASND
- Stock Information
- Founded
- COKE 1902
- ASND 2006
- Country
- COKE United States
- ASND Denmark
- Employees
- COKE N/A
- ASND N/A
- Industry
- COKE Beverages (Production/Distribution)
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- COKE Consumer Staples
- ASND Health Care
- Exchange
- COKE Nasdaq
- ASND Nasdaq
- Market Cap
- COKE 11.7B
- ASND 9.9B
- IPO Year
- COKE N/A
- ASND 2015
- Fundamental
- Price
- COKE $1,350.00
- ASND $155.86
- Analyst Decision
- COKE
- ASND Strong Buy
- Analyst Count
- COKE 0
- ASND 14
- Target Price
- COKE N/A
- ASND $201.79
- AVG Volume (30 Days)
- COKE 52.5K
- ASND 417.3K
- Earning Date
- COKE 05-05-2025
- ASND 05-01-2025
- Dividend Yield
- COKE 0.74%
- ASND N/A
- EPS Growth
- COKE 60.86
- ASND N/A
- EPS
- COKE 69.94
- ASND N/A
- Revenue
- COKE $6,899,716,000.00
- ASND $376,478,932.00
- Revenue This Year
- COKE N/A
- ASND $58.89
- Revenue Next Year
- COKE N/A
- ASND $75.85
- P/E Ratio
- COKE $19.02
- ASND N/A
- Revenue Growth
- COKE 3.69
- ASND 36.34
- 52 Week Low
- COKE $800.76
- ASND $111.09
- 52 Week High
- COKE $1,460.92
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- COKE 53.94
- ASND 51.63
- Support Level
- COKE $1,268.23
- ASND $161.50
- Resistance Level
- COKE $1,334.48
- ASND $161.91
- Average True Range (ATR)
- COKE 32.32
- ASND 5.94
- MACD
- COKE 4.16
- ASND -1.25
- Stochastic Oscillator
- COKE 80.38
- ASND 47.14
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.